Augmedix Research and Development Expenses 2019-2023 | AUGX

Augmedix research and development expenses from 2019 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
Augmedix Annual Research and Development Expenses
(Millions of US $)
2023 $11
2022 $10
2021 $7
2020 $5
2019 $7
Augmedix Quarterly Research and Development Expenses
(Millions of US $)
2023-12-31 $3
2023-09-30 $3
2023-06-30 $3
2023-03-31 $3
2022-12-31 $3
2022-09-30 $3
2022-06-30 $3
2022-03-31 $2
2021-12-31 $2
2021-09-30 $2
2021-06-30 $1
2021-03-31 $1
2020-12-31 $1
2020-09-30 $1
2020-06-30 $1
2020-03-31 $1
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.109B $0.045B
Augmedix Inc. is a provider of remote medical documentation and live clinical support. Augmedix Inc. is based in SAN FRANCISCO, Calif.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $38.069B 20.90
Inspire Medical Systems (INSP) United States $4.986B 0.00
Axonics (AXNX) United States $3.440B 0.00
10x Genomics (TXG) United States $3.097B 0.00
IRhythm Technologies (IRTC) United States $3.080B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.900B 0.00
Azenta (AZTA) United States $2.877B 156.36
Enovis (ENOV) United States $2.801B 20.76
Hims & Hers Health (HIMS) United States $2.633B 0.00
Privia Health (PRVA) United States $2.132B 119.80
Schrodinger (SDGR) United States $1.644B 0.00
Omnicell (OMCL) United States $1.383B 47.81
Phreesia (PHR) United States $1.205B 0.00
Standard BioTools (LAB) United States $0.696B 0.00
Fulgent Genetics (FLGT) United States $0.651B 0.00
Definitive Healthcare (DH) United States $0.627B 0.00
Talkspace (TALK) United States $0.477B 0.00
Clover Health Investments (CLOV) United States $0.406B 0.00
Health Catalyst (HCAT) United States $0.378B 0.00
Pulmonx (LUNG) United States $0.326B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.306B 0.00
Butterfly Network (BFLY) United States $0.215B 0.00
P3 Health Partners (PIII) United States $0.212B 0.00
Outset Medical (OM) United States $0.159B 0.00
American Well (AMWL) United States $0.139B 0.00
TruBridge (TBRG) United States $0.129B 7.07
MSP Recovery (LIFW) United States $0.121B 0.00
111 (YI) China $0.095B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.078B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.061B 0.00
EUDA Health Holdings (EUDA) Singapore $0.055B 0.00
Zepp Health (ZEPP) China $0.053B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
Movano (MOVE) United States $0.043B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.034B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.021B 0.00
Cue Health (HLTH) United States $0.021B 0.00
CareCloud (CCLD) United States $0.020B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Syra Health (SYRA) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00